Attenuated Salmonella and Shigella as Carriers for DNA Vaccines

References

• al-Ramadi, B.K., Adeghate, E., Mustafa, N., Ponery, A.S. and Fernandez- Cabezudo, M.J. (2002) “Cytokine expression by attenuated intracellular bacteria regulates the immune response to infection: the Salmonella model”, Mol. Immunol. 38, 931–940.
   Web of Science ®Google Scholar
• Anderson, R.J., Pasetti, M.F., Sztein, M.B., Levine, M.M. and Noriega, F.R. (2000) “DguaBA attenuated Shigella flexneri 2a strain CVD 1204 as a Shigella vaccine and as a live mucosal delivery system for fragment C of tetanus toxin”, Vaccine 18, 2193–2202.
   Google Scholar
• Attridge, S.R., Davies, R. and LaBrooy, J.T. (1997) “Oral delivery of foreign antigens by attenuated Salmonella: consequences of prior exposure to the vector strain”, Vaccine 15, 155–162.
   PubMed Web of Science ®Google Scholar
• Bao, J.X. and Clements, J.D. (1991) “Prior immunologic experience potentiates the subsequent antibody response when Salmonella strains are used as vaccine carriers”, Infect. Immun. 59, 3841–3845.
   Google Scholar
• Barthel, M., Hapfelmeier, S., Quintanilla-Martinez, L., Kremer, M., Rohde, M., Hogardt, M., Pfeffer, K., Russmann, H. and Hardt, W.D. (2003) “Pretreatment of mice with streptomycin provides a Salmonella enterica serovar typhimurium colitis model that allows analysis of both pathogen and host”, Infect. Immun. 71, 2839-2858. Berglund, P., Smerdou, C., Fleeton, M.N., Tubulekas, I. and Liljestrom, P. (1998) “Enhancing immune responses using suicidal DNA vaccines”, Nat. Biotechnol. 16, 562–565.
   Google Scholar
• Berzofsky, J.A., Ahlers, J.D., Derby, M.A., Pendleton, C.D., Arichi, T. and Belyakov, I.M. (1999) “Approaches to improve engineered vaccines for human immunodeficiency virus and other viruses that cause chronic infections”, Immunol. Rev. 170, 151–172.
   Google Scholar
• Brunham, R.C. and Zhang, D. (1999) “Transgene as vaccine for Chlamydia”, Am. Heart J. 138, S519–S522.
   PubMed Web of Science ®Google Scholar
• Chatfield, S.N., Strahan, K., Pickard, D., Charles, I.G., Hormaeche, C.E. and Dougan, G. (1992) “Evaluation of Salmonella typhimurium strains harbouring defined mutations in htrA and aroA in the murine salmonellosis model”, Microb. Pathog. 12, 145–151.
   Google Scholar
• Chatfield, S., Roberts, M., Li, J., Starns, A. and Dougan, G. (1994) “The use of live attenuated Salmonella for oral vaccination”, Dev. Biol. Stand. 82, 35–42.
   PubMedGoogle Scholar
• Cicin-Sain, L., Brune, W., Bubic, I., Jonjic, S. and Koszinowski, U.H. (2003) “Vaccination of mice with bacteria carrying a cloned herpesvirus genome reconstituted in vivo”, J. Virol. 77, 8249–8255.
   Web of Science ®Google Scholar
• Cochlovius, B., Stassar, M.J., Schreurs, M.W., Benner, A. and Adema, G.J. (2002) “Oral DNA vaccination: antigen uptake and presentation by dendritic cells elicits protective immunity”, Immunol. Lett. 80, 89–96.
   Google Scholar
• Covone, M.G., Brocchi, M., Palla, E., Dias da Silveira, W., Rappuoli, R. and Galeotti, C.L. (1998) “Levels of expression and immunogenicity of attenuated Salmonella enterica serovar typhimurium strains expressing Escherichia coli mutant heat-labile enterotoxin”, Infect. Immun. 66, 224–231.
   Google Scholar
• Darji, A., zur Lage, S., Garbe, A.I., Chakraborty, T. and Weiss, S. (2000) “Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier”, FEMS Immunol. Med. Microbiol. 27, 341–349.
   Google Scholar
• Devico, A.L., Fouts, T.R., Shata, M.T., Kamin-Lewis, R., Lewis, G.K. and Hone, D.M. (2002) “Development of an oral prime-boost strategy to elicit broadly neutralizing antibodies against HIV-1”, Vaccine 20, 1968–1974.
   PubMed Web of Science ®Google Scholar
• Dietrich, G., Bubert, A., Gentschev, I., Sokolovic, Z., Simm, A., Catic, A., Kaufmann, S.H., Hess, J., Szalay, A.A. and Goebel, W. (1998) “Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes”, Nat. Biotechnol. 16, 181–185.
   Google Scholar
• Donnelly, J.J., Ulmer, J.B. and Liu, M.A. (1997) “DNA vaccines”, Life Sci. 60, 163–172.
   PubMed Web of Science ®Google Scholar
• Elias, F. and Flo, J. (2002) “Modulation of the immune response mediated by oral transgene administration of IL-10”, Cell Immunol. 216, 73–81.
   PubMed Web of Science ®Google Scholar
• Fairweather, N.F., Chatfield, S.N., Charles, I.G., Roberts, M., Lipscombe, M., Li, L.J., Strugnell, D., Comerford, S., Tite, J. and Dougan, G. (1990) “Use of live attenuated bacteria to stimulate immunity”, Res. Microbiol. 141, 769–773.
   Web of Science ®Google Scholar
• Fennelly, G.J., Khan, S.A., Abadi, M.A., Wild, T.F. and Bloom, B.R. (1999) “Mucosal DNA vaccine immunization against measles with a highly attenuated Shigella flexneri vector”, J. Immunol. 162, 1603–1610.
   Web of Science ®Google Scholar
• Fernandez, M.I., Thuizat, A., Pedron, T., Neutra, M., Phalipon, A. and Sansonetti, P.J. (2003) “A newborn mouse model for the study of intestinal pathogenesis of shigellosis”, Cell Microbiol. 5, 481–491.
   PubMed Web of Science ®Google Scholar
• Flo, J., Tisminetzky, S. and Baralle, F. (2001) “Oral transgene vaccination mediated by attenuated Salmonellae is an effective method to prevent Herpes simplex virus-2 induced disease in mice”, Vaccine 19, 1772–1782.
   PubMed Web of Science ®Google Scholar
• Fouts, T.R., Tuskan, R.G., Chada, S., Hone, D.M. and Lewis, G.K. (1995) “Construction and immunogenicity of Salmonella typhimurium vaccine vectors that express HIV-1 gp120”, Vaccine 13, 1697–1705.
   Google Scholar
• Galan, J.E. and Curtiss, 3rd, R. (1989) “Virulence and vaccine potential of phoP mutants of Salmonella typhimurium”, Microb. Pathog. 6, 433–443.
   Google Scholar
• Galan, J.E., Nakayama, K. and Curtiss, 3rd, R. (1990) “Cloning and characterization of the asd gene of Salmonella typhimurium: use in stable maintenance of recombinant plasmids in Salmonella vaccine strains”, Gene 94, 29–35.
   Google Scholar
• Garcia-del Portillo, F. and Finlay, B.B. (1995) “The varied lifestyles of intracellular pathogens within eukaryotic vacuolar compartments”, Trends Microbiol. 3, 373–380.
   PubMed Web of Science ®Google Scholar
• Gentschev, I., Mollenkopf, H., Sokolovic, Z., Hess, J., Kaufmann, S.H. and Goebel, W. (1996) “Development of antigen-delivery systems, based on the Escherichia coli hemolysin secretion pathway”, Gene 179, 133–140.
   PubMed Web of Science ®Google Scholar
• Gentschev, I., Glaser, I., Goebel, W., McKeever, D.J., Musoke, A. and Heussler, V.T. (1998) “Delivery of the p67 sporozoite antigen of Theileria parva by using recombinant Salmonella dublin: secretion of the product enhances specific antibody responses in cattle”, Infect. Immun. 66, 2060–2064.
   Google Scholar
• Gentschev, I., Dietrich, G., Spreng, S., Kolb-Maurer, A., Brinkmann, V., Grode, L., Hess, J., Kaufmann, S.H. and Goebel, W. (2001) “Recombinant attenuated bacteria for the delivery of subunit vaccines”, Vaccine 19, 2621–2628.
   PubMed Web of Science ®Google Scholar
• Grillot-Courvalin, C., Goussard, S., Huetz, F., Ojcius, D.M. and Courvalin, P. (1998) “Functional gene transfer from intracellular bacteria to mammalian cells”, Nat. Biotechnol. 16, 862–866.
   Google Scholar
• Grillot-Courvalin, C., Goussard, S. and Courvalin, P. (2002) “Wild-type intracellular bacteria deliver DNA into mammalian cells”, Cell Microbiol. 4, 177–186.
   PubMed Web of Science ®Google Scholar
• Gurunathan, S., Klinman, D.M. and Seder, R.A. (2000) “DNA vaccines: immunology, application, and optimization”, Annu. Rev. Immunol. 18, 927–974.
   Google Scholar
• Hantman, M.J., Hohmann, E.L., Murphy, C.G., Knipe, D.M. and Miller, S.I. (1999) “Antigen Delivery Systems: development of recombinant live vaccines using viral or bacterial vectors”, In: Ogra, P.L., Mestecky, J., Lamm, M.E., Strober, W., Bienenstrock, J. and McGhee, J.R., eds, Mucosal Immunology, 2nd Ed. (Academic Press, San Diego), pp 779–791.
   Google Scholar
• Hess, J., Gentschev, I., Miko, D., Welzel, M., Ladel, C., Goebel, W. and Kaufmann, S.H. (1996) “Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis”, Proc. Natl Acad. Sci. USA 93, 1458–1463.
   PubMed Web of Science ®Google Scholar
• Hoiseth, S.K. and Stocker, B.A. (1981) “Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines”, Nature 291, 238–239.
   PubMed Web of Science ®Google Scholar
• Hume, P.J., McGhie, E.J., Hayward, R.D. and Koronakis, V. (2003) “The purified Shigella IpaB and Salmonella SipB translocators share biochemical properties and membrane topology”, Mol. Microbiol. 49, 425–439.
   Web of Science ®Google Scholar
• Jain, V. and Mekalanos, J.J. (2000) “Use of lambda phage S and R gene products in an inducible lysis system for Vibrio cholerae- and Salmonella enterica serovar typhimurium-based DNA vaccine delivery systems”, Infect. Immun. 68, 986–989.
   Google Scholar
• Janeway, Jr., C.A. and Medzhitov, R. (2002) “Innate immune recognition”, Annu. Rev. Immunol. 20, 197–216.
   Google Scholar
• Kang, H.Y., Srinivasan, J. and Curtiss, 3rd, R. (2002) “Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar typhimurium vaccine”, Infect. Immun. 70, 1739–1749.
   Google Scholar
• Lee, J.J., Sinha, K.A., Harrison, J.A., de Hormaeche, R.D., Riveau, G., Pierce, R.J., Capron, A., Wilson, R.A. and Khan, C.M. (2000) “Tetanus toxin fragment C expressed in live Salmonella vaccines enhances antibody responses to its fusion partner Schistosoma haematobium glutathione S-transferase”, Infect. Immun. 68, 2503–2512.
   Google Scholar
• Lehner, T., Wang, Y., Ping, L., Bergmeier, L., Mitchell, E., Cranage, M., Hall, G., Dennis, M., Cook, N., Doyle, C. and Jones, I. (1999) “The effect of route of immunization on mucosal immunity and protection”, J. Infect. Dis. 179, S489–S492.
   Google Scholar
• Lode, H.N., Pertl, U., Xiang, R., Gaedicke, G. and Reisfeld, R.A. (2000) “Tyrosine hydroxylase-based DNA-vaccination is effective against murine neuroblastoma”, Med. Pediatr. Oncol. 35, 641-646. Luo, Y., Zhou, H., Mizutani, M., Mizutani, N., Reisfeld, R.A. and Xiang, (2003) “Transcription factor Fos-related antigen 1 is an effective target for a breast cancer vaccine”, Proc. Natl Acad. Sci. USA 100, 8850–8855.
   Google Scholar
• Maloy, K.J., Erdmann, I., Basch, V., Sierro, S., Kramps, T.A., Zinkernagel, R.M., Oehen, S. and Kundig, T.M. (2001) “Intralym- phatic immunization enhances DNA vaccination”, Proc. Natl Acad. Sci. USA 98, 3299–3303.
   PubMed Web of Science ®Google Scholar
• McNeill, H.V., Sinha, K.A., Hormaeche, C.E., Lee, J.J. and Khan, C.M. (2000) “Development of a nonantibiotic dominant marker for positively selecting expression plasmids in multivalent Salmonella vaccines”, Appl. Environ. Microbiol. 66, 1216–1219.
   Web of Science ®Google Scholar
• Miller, I., Maskell, D., Hormaeche, C., Johnson, K., Pickard, D. and Dougan, G. (1989) “Isolation of orally attenuated Salmonella typhimurium following TnphoA mutagenesis”, Infect. Immun. 57, 2758–2763.
   Google Scholar
• Miller, S.I., Mekalanos, J.J. and Pulkkinen, W.S. (1990) “Salmonella vaccines with mutations in the phoP virulence regulon”, Res. Microbiol. 141, 817–821.
   Web of Science ®Google Scholar
• Mollenkopf, H.J., Groine-Triebkorn, D., Andersen, P., Hess, J. and Kaufmann, S.H. (2001) “Protective efficacy against tuberculosis of ESAT-6 secreted by a live Salmonella typhimurium vaccine carrier strain and expressed by naked DNA”, Vaccine 19, 4028–4035.
   Google Scholar
• Nakayama, K., Kelly, S.M. and Curtiss, III, R. (1988) “Construction of an Asd+ expression-cloning vector: Stable maintenance and high level expression of cloned genes in a Salmonella vaccine strain”, Biotechnology (NY) 6, 693–697.
   Google Scholar
• Nataro, J.P. and Levine, M.M. (1999) “Enteric Bacterial Vaccines: Salmonella, Shigella, Cholera, Escherichia coli”, In: Ogra, P.L., Mestecky, J., Lamm, M.E., Strober, W., Bienenstock, J. and McGhee, J.R., eds, Mucosal Immunology, 2nd Ed. (Academic Press, San Diego), pp 851–865.
   Google Scholar
• Neutra, M.R., Frey, A. and Kraehenbuhl, J.P. (1996) “Epithelial M cells: gateways for mucosal infection and immunization”, Cell 86, 345–348.
   Google Scholar
• Niethammer, A.G., Primus, F.J., Xiang, R., Dolman, C.S., Ruehlmann, J.M., Ba, Y., Gillies, S.D. and Reisfeld, R.A. (2001a) “An oral DNA vaccine against human carcinoembryonic antigen (CEA) prevents growth and dissemination of Lewis lung carcinoma in CEA transgenic mice”, Vaccine 20, 421–429.
   Google Scholar
• Niethammer, A.G., Xiang, R., Ruehlmann, J.M., Lode, H.N., Dolman, C.S., Gillies, S.D. and Reisfeld, R.A. (2001b) “Targeted interleukin 2 therapy enhances protective immunity induced by an autologous oral DNA vaccine against murine melanoma”, Cancer Res. 61, 6178–6184.
   PubMed Web of Science ®Google Scholar
• Noriega, F.R., Losonsky, G., Lauderbaugh, C., Liao, F.M., Wang, J.Y. and Levine, M.M. (1996) “Engineered DguaB-A DvirG Shigella flexneri 2a strain CVD 1205: construction, safety, immunogenicity, and potential efficacy as a mucosal vaccine”, Infect. Immun. 64, 3055–3061.
   Google Scholar
• O’Callaghan, D., Maskell, D., Liew, F.Y., Easmon, C.S. and Dougan, G. (1988) “Characterization of aromatic- and purine-dependent Salmonella typhimurium: attention, persistence, and ability to induce protective immunity in BALB/c mice”, Infect. Immun. 56, 419-423. Paglia, P., Medina, E., Arioli, I., Guzman, C.A. and Colombo, M.P. (1998) “Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma”, Blood 92, 3172–3176.
   Google Scholar
• Pasetti, M.F., Anderson, R.J., Noriega, F.R., Levine, M.M. and Sztein, M.B. (1999) “Attenuated DguaBA Salmonella typhi vaccine strain CVD 915 as a live vector utilizing prokaryotic or eukaryotic expression systems to deliver foreign antigens and elicit immune responses”, Clin. Immunol. 92, 76–89.
   Web of Science ®Google Scholar
• Pasetti, M.F., Barry, E.M., Losonsky, G., Singh, M., Medina-Moreno, S.M., Polo, J.M., Ulmer, J., Robinson, H., Sztein, M.B. and Levine, M.M. (2003) “Attenuated Salmonella enterica serovar typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats”, J. Virol. 77, 5209–5217.
   Web of Science ®Google Scholar
• Pertl, U., Wodrich, H., Ruehlmann, J.M., Gillies, S.D., Lode, H.N. and Reisfeld, R.A. (2003) “Immunotherapy with a posttranscriptionally modified DNA vaccine induces complete protection against metastatic neuroblastoma”, Blood 101, 649–654.
   PubMed Web of Science ®Google Scholar
• Rescigno, M., Urbano, M., Valzasina, B., Francolini, M., Rotta, G., Bonasio, R., Granucci, F., Kraehenbuhl, J.P. and Ricciardi- Castagnoli, P. (2001) “Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria”, Nat. Immunol. 2, 361–367.
   Web of Science ®Google Scholar
• Roberts, M., Bacon, A., Li, J. and Chatfield, S. (1999) “Prior immunity to homologous and heterologous Salmonella serotypes suppresses local and systemic anti-fragment C antibody responses and protection from tetanus toxin in mice immunized with Salmonella strains expressing fragment C”, Infect. Immun. 67, 3810–3815.
   Google Scholar
• Rosenkranz, C.D., Chiara, D., Agorio, C., Baz, A., Pasetti, M.F., Schreiber, F., Dematteis, S., Martinez, M., Sztein, M.B. and Chabalgoity, J.A. (2003) “Towards new immunotherapies: targeting recombinant cytokines to the immune system using live attenuated Salmonella”, Vaccine 21, 798–801.
   PubMed Web of Science ®Google Scholar
• Sansonetti, P. (2001) “Phagocytosis of bacterial pathogens: implications in the host response”, Semin. Immunol. 13, 381–390.
   Web of Science ®Google Scholar
• Sansonetti, P. (2002) “Host-pathogen interactions: the seduction of molecular cross talk”, Gut 50(Suppl. 3), III 2-III 8.
   Google Scholar
• Schaffner, W. (1980) “Direct transfer of cloned genes from bacteria to mammalian cells”, Proc. Natl Acad. Sci. USA 77, 2163–2167.
   PubMed Web of Science ®Google Scholar
• Shata, M.T. and Hone, D.M. (2001) “Vaccination with a Shigella DNA vaccine vector induces antigen-specific CD8+ T cells and antiviral protective immunity”, J. Virol. 75, 9665–9670.
   Web of Science ®Google Scholar
• Shata, M.T., Reitz, Jr, M.S., DeVico, A.L., Lewis, G.K. and Hone, D.M. (2001) “Mucosal and systemic HIV-1 Env-specific CD8+ T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector”, Vaccine 20, 623–629.
   Google Scholar
• Siebers, A. and Finlay, B.B. (1996) “M cells and the pathogenesis of mucosal and systemic infections”, Trends Microbiol. 4, 22-29. Sizemore, D.R., Branstrom, A.A. and Sadoff, J.C. (1995) “Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immuniz- ation”, Science 270, 299–302.
   Google Scholar
• Stocker, B.A. and Newton, S.M. (1994) “Immune responses to epitopes inserted in Salmonella flagellin”, Int. Rev. Immunol. 11, 167–178.
   Google Scholar
• Takeuchi, A. (1967) “Electron microscope studies of experimental Salmonella infection. I. Penetration into the intestinal epithelium by Salmonella typhimurium”, Am. J. Pathol. 50, 109–136.
   PubMed Web of Science ®Google Scholar
• Tsolis, R.M., Kingsley, R.A., Townsend, S.M., Ficht, T.A., Adams, L.G. and Baumler, A.J. (1999) “Of mice, calves, and men. Comparison of the mouse typhoid model with other Salmonella infections”, Adv. Exp. Med. Biol. 473, 261–274.
   PubMed Web of Science ®Google Scholar
• Tvinnereim, A.R., Hamilton, S.E. and Harty, J.T. (2002) “CD8+-T-cell response to secreted and nonsecreted antigens delivered by recombinant Listeria monocytogenes during secondary infection”, Infect. Immun. 70, 153–162.
   Google Scholar
• Vazquez-Torres, A., Jones-Carson, J., Baumler, A.J., Falkow, S., Valdivia, R., Brown, W., Le, M., Berggren, R., Parks, W.T. and Fang, F.C. (1999) “Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes”, Nature 401, 804–808.
   PubMed Web of Science ®Google Scholar
• Vecino, W.H., Morin, P.M., Agha, R., Jacobs, Jr., W.R. and Fennelly, G.J. (2002) “Mucosal DNA vaccination with highly attenuated Shigella is superior to attenuated Salmonella and comparable to intramuscular DNA vaccination for T cells against HIV”, Immunol. Lett. 82, 197–204.
   Google Scholar
• Wallis, T.S. and Galyov, E.E. (2000) “Molecular basis of Salmonella- induced enteritis”, Mol. Microbiol. 36, 997–1005.
   Web of Science ®Google Scholar
• Wedemeyer, H., Gagneten, S., Davis, A., Bartenschlager, R., Feinstone, and Rehermann, B. (2001) “Oral immunization with HCV-NS3- transformed Salmonella: induction of HCV-specific CTL in a transgenic mouse model”, Gastroenterology 121, 1158–1166.
   Google Scholar
• Weth, R., Christ, O., Stevanovic, S. and Zoller, M. (2001) “Gene delivery by attenuated Salmonella typhimurium: comparing the efficacy of helper versus cytotoxic T cell priming in tumor vaccination”, Cancer Gene Ther. 8, 599–611.
   PubMed Web of Science ®Google Scholar
• Whittle, B.L. and Verma, N.K. (1997) “The immune response to a B-cell epitope delivered by Salmonella is enhanced by prior immunological experience”, Vaccine 15, 1737–1740.
   PubMed Web of Science ®Google Scholar
• Wong, L.P., Woo, P.C., Wu, A.Y. and Yuen, K.Y. (2002) “DNA immunization using a secreted cell wall antigen Mp1p is protective against Penicillium marneffei infection”, Vaccine 20, 2878–2886.
   PubMed Web of Science ®Google Scholar
• Woo, P.C., Wong, L.P., Zheng, B.J. and Yuen, K.Y. (2001) “Unique immunogenicity of hepatitis B virus DNA vaccine presented by live-attenuated Salmonella typhimurium”, Vaccine 19, 2945–2954.
   Google Scholar
• Xiang, R., Lode, H.N., Chao, T.H., Ruehlmann, J.M., Dolman, C.S., Rodriguez, F., Whitton, J.L., Overwijk, W.W., Restifo, N.P. and Reisfeld, R.A. (2000) “An autologous oral DNA vaccine protects against murine melanoma”, Proc. Natl Acad. Sci. USA 97, 5492–5497.
   PubMed Web of Science ®Google Scholar
• Xiang, R., Primus, F.J., Ruehlmann, J.M., Niethammer, A.G., Silletti, S., Lode, H.N., Dolman, C.S., Gillies, S.D. and Reisfeld, R.A. (2001a) “A dual-function DNA vaccine encoding carcinoembryonic antigen and CD40 ligand trimer induces T cell-mediated protective immunity against colon cancer in carcinoembryonic antigen-transgenic mice”, J. Immunol. 167, 4560–4565.
   Web of Science ®Google Scholar
• Xiang, R., Silletti, S., Lode, H.N., Dolman, C.S., Ruehlmann, J.M., Niethammer, A.G., Pertl, U., Gillies, S.D., Primus, F.J. and Reisfeld, R.A. (2001b) “Protective immunity against human carcinoembryonic antigen (CEA) induced by an oral DNA vaccine in CEA-transgenic mice”, Clin. Cancer Res. 7, 856s-864s.
   Google Scholar
• Xu, F., Hong, M. and Ulmer, J.B. (2003) “Immunogenicity of an HIV-1 gag DNA vaccine carried by attenuated Shigella”, Vaccine 21, 644–648.
   Google Scholar
• Zoller, M. and Christ, O. (2001) “Prophylactic tumor vaccination: comparison of effector mechanisms initiated by protein versus DNA vaccination”, J. Immunol. 166, 3440–3450.
   Web of Science ®Google Scholar